Henriksen Ulla, Fog Jacob U, Litman Thomas, Gether Ulrik
Molecular Neuropharmacology Group, Department of Pharmacology, Panum Institute, Building 18.6, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
J Biol Chem. 2005 Nov 4;280(44):36926-34. doi: 10.1074/jbc.M502937200. Epub 2005 Aug 17.
ABCG2 is an ATP binding cassette (ABC) half-transporter that plays a key role in multidrug resistance to chemotherapy. ABCG2 is believed to be a functional homodimer that has been proposed to be linked by disulfide bridges. We have investigated the structural and functional role of the only three cysteines predicted to be on the extracellular face of ABCG2. Upon mutation of Cys-592 or Cys-608 to alanine (C592A and C608A), ABCG2 migrated as a dimer in SDS-PAGE under non-reducing conditions; however, mutation of Cys-603 to Ala (C603A) caused the transporter to migrate as a single monomeric band. Despite this change, C603A displayed efficient membrane targeting and preserved transport function. Because the transporter migrated as a dimer in SDS-PAGE, when only Cys-603 was present (C592A-C608A), the data suggest that Cys-603 forms a symmetrical intermolecular disulfide bridge in the ABCG2 homodimer that is not essential for protein expression and function. In contrast to C603A, both C592A and C608A displayed impaired membrane targeting and function. Moreover, when only Cys-592 or Cys-608 were present (C592A/C603A and C603A/C608A), the transporter displayed impaired plasma membrane expression and function. The combined mutation (C592A/C608A) partially restored plasma membrane expression; however, although transport of mitoxantrone was almost normal, we observed impairment of BODIPY-prazosin transport. This supports the conclusion that Cys-592 and Cys-608 form an intramolecular disulfide bridge in ABCG2 that is critical for substrate specificity. Finally, mutation of all three cysteines simultaneously resulted in low expression and no measurable function. Altogether, our data are consistent with a scenario in which an inter- and an intramolecular disulfide bridge together are of fundamental importance for the structural and functional integrity of ABCG2.
ABCG2是一种ATP结合盒(ABC)半转运蛋白,在化疗多药耐药中起关键作用。ABCG2被认为是一种功能性同型二聚体,有人提出它通过二硫键相连。我们研究了预测位于ABCG2细胞外表面的仅有的三个半胱氨酸的结构和功能作用。将半胱氨酸-592(Cys-592)或半胱氨酸-608(Cys-608)突变为丙氨酸(C592A和C608A)后,在非还原条件下,ABCG2在SDS-PAGE中以二聚体形式迁移;然而,将半胱氨酸-603(Cys-603)突变为丙氨酸(C603A)导致转运蛋白以单一的单体条带形式迁移。尽管有这种变化,C603A仍表现出有效的膜靶向并保留了转运功能。由于转运蛋白在SDS-PAGE中以二聚体形式迁移,当仅存在半胱氨酸-603(C592A-C608A)时,数据表明半胱氨酸-603在ABCG2同型二聚体中形成对称的分子间二硫键,这对蛋白质表达和功能并非必需。与C603A相反,C592A和C608A均表现出膜靶向和功能受损。此外,当仅存在半胱氨酸-592或半胱氨酸-608(C592A/C603A和C603A/C608A)时,转运蛋白表现出质膜表达和功能受损。联合突变(C592A/C608A)部分恢复了质膜表达;然而,尽管米托蒽醌的转运几乎正常,但我们观察到BODIPY-哌唑嗪转运受损。这支持了半胱氨酸-592和半胱氨酸-608在ABCG2中形成分子内二硫键对底物特异性至关重要的结论。最后,同时将所有三个半胱氨酸突变导致低表达且无可测量的功能。总之,我们的数据与一种情况一致,即分子间和分子内二硫键共同对ABCG2的结构和功能完整性至关重要。